gastric-cancer

Documents about gastric-cancer

• Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers#804659ClinicalTrials.gov
• COMPARATIVE EFFECTS OF PERIOPERATIVE AND ADJUVANT CHEMOTHERAPY ON OUTCOMES OF OPERABLE GASTRIC CANCER: EXPERIENCE FROM A CANCER CARE CENTER#982011ClinicalTrials.gov
• A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)#366615ClinicalTrials.gov
• MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment#883655ClinicalTrials.gov
• Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer#966127ClinicalTrials.gov
• Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer#866169ClinicalTrials.gov
• Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer#674904ClinicalTrials.gov
• Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.#411377ClinicalTrials.gov
• A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer#810065ClinicalTrials.gov
• Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS Study#899350ClinicalTrials.gov
• Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma#828782ClinicalTrials.gov
• Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy#845328ClinicalTrials.gov
• The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer#853339ClinicalTrials.gov
• Short-term Outcomes of Laparoscopic Versus Open Gastrectomy With Lymph Node Dissection for Early Gastric Cancer :a Randomized Controlled Study#858463ClinicalTrials.gov
• Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer#861807ClinicalTrials.gov
• Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus#863960ClinicalTrials.gov
• Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric Cancer#865034ClinicalTrials.gov
• The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer#865521ClinicalTrials.gov
• Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab.#869113ClinicalTrials.gov
• Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer#884123ClinicalTrials.gov
• Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.#906289ClinicalTrials.gov
• Early Recovery After Gastric Cancer Surgery#1007107ClinicalTrials.gov
• Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma#850617ClinicalTrials.gov
• Effect of Smart Phone App-based Human Coaching Program in Gastrectomized Patients#901584ClinicalTrials.gov
• Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors#851445ClinicalTrials.gov
• Oncometabolic Surgery#968566ClinicalTrials.gov
• Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors#839349ClinicalTrials.gov
• Personalized DC Vaccine for Postoperative Cancer#141079ClinicalTrials.gov
• Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer#349959ClinicalTrials.gov
• PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer#394746ClinicalTrials.gov
• The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial#481752ClinicalTrials.gov
• Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients#829821ClinicalTrials.gov
• Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer#834969ClinicalTrials.gov
• Laparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer#840702ClinicalTrials.gov
• Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography#849937ClinicalTrials.gov
• Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma#855509ClinicalTrials.gov
• RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX#886193ClinicalTrials.gov
• Enhanced Recovery After Surgery(ERAS) for Gastric Cancer and Perioperative Nutritional Status#886622ClinicalTrials.gov
• Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric Cancer#888343ClinicalTrials.gov
• Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer#889761ClinicalTrials.gov
• Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer#906372ClinicalTrials.gov
• Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance#936000Repositorio de Universidad Autónoma de Chile.
• Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients#856270ClinicalTrials.gov
• Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy#226254ClinicalTrials.gov
• Tumor context determines ARID1A effects on gastric cancer immunity#1006962bioRxiv / medRxiv
• Avastin and Taxotere for Esophagogastric Cancer#867953ClinicalTrials.gov
• Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.#889858ClinicalTrials.gov
• Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy#801261ClinicalTrials.gov
• A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer#871557ClinicalTrials.gov
• Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors#829094ClinicalTrials.gov